Search

Displaying results 8371 - 8380 of 10000 in total
  1. Drug

    Lutetium Lu 177-DTPA-omburtamab

    go.drugbank.com/drugs/DB31015
    Investigational

    Lutetium Lu 177-DTPA-omburtamab is a radioimmunoconjugate made up of [omburtamab] conjugated with lutetium Lu 177 via the chelating agent of diethylenetriaminepentaacetic acid (DTPA).[L54566]

  2. Drug

    CX-052075

    go.drugbank.com/drugs/DB31655
    Approved

    CX-052075 is a nucleoside-modified messenger RNA (mRNA) encoding the N-terminal domain (NTD) and receptor-binding domain (RBD) of the spike glycoprotein of the SARS-CoV-2 Omicron variant sublineage LP.8.1 … spike protein, allowing for a more targeted immune response and the use of a significantly smaller amount of mRNA per dose.

  3. Drug

    FRAX597

    go.drugbank.com/drugs/DB31734
    Experimental

    FRAX597 is a small molecule drug that inhibits the p21-activated kinases (PAKs).[A274673, A274678]

    Categories: Heterocyclic Compounds, 1-Ring
  4. Drug

    Copper histidinate

    go.drugbank.com/drugs/DB32041
    Approved

    Menkes disease is a rare, X-linked recessive disorder caused by pathogenic variants in the ATP7A gene, which encodes a copper transport protein essential for absorbing dietary copper and transporting it … [A275383] Copper histidinate is a subcutaneously-administered copper-histidine complex that allows for copper supplementation in patients with defective ATP7A transporters.

  5. Drug

    IL21120033

    go.drugbank.com/drugs/DB32508
    Experimental

    IL21120033 is a first-in-class, small-molecule selective CXCR7 agonist.

  6. Drug

    ZKN-013

    go.drugbank.com/drugs/DB32582
    Experimental

    ZKN-013 is a readthrough inducer under investigation for rare dermatological diseases.[L56075]

  7. Drug

    SW033291

    go.drugbank.com/drugs/DB32765
    Experimental

    SW033291 is a small molecule 15-hydroxyprostaglandin dehydrogenase (15-PGDH) inhibitor. … [A275473, A275474] It has been found to increase prostaglandin E2 (PGE2) and is being investigated in accelerating of hematopoietic recovery and treating type 2 diabetes mellitus.[A275473, A275474]

    Synonyms: 2-(Butane-1-sulfinyl)-4-phenyl-6-thiophen-2-yl-thieno[2,3-b]pyridin-3-ylamineCategories: Heterocyclic Compounds, 1-Ring
  8. Drug

    GLB-008

    go.drugbank.com/drugs/DB32800
    Experimental

    GLB-008 is a molecular glue degrader targeting VAV1.[L56125, L56126]

  9. Drug

    XM146-MPA-SN38

    go.drugbank.com/drugs/DB32865
    Experimental

    XM146-MPA-SN38 is a PDL1-targeting polypeptide-MPA-SN38 conjugate.

  10. Drug

    TN-301

    go.drugbank.com/drugs/DB32867
    Experimental

    TN-301 is a small-molecule histone deacetylase 6 inhibitor.